AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.9 Out of 5 (5239 Reviews)

What I like most about KSquare is the clarity and control I have over my investments. SIPs have never been easier to manage.

Nikhil Arora

Nikhil Arora

UX Designer

KSquare’s recommendations are on point. Their mutual fund picks are backed by solid research, and I’ve seen consistent returns over the past year.

Arvind Joshi

Arvind Joshi

Civil Contractor

New fund investing used to be intimidating. KSquare’s support and transparency made it not only easy but enjoyable. I now look forward to NFOs!

Ashwin Nambiar

Ashwin Nambiar

Logistics Planner

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

I’ve tested many platforms, but KSquare stands out for their transparency and consistent performance. SIPs with them feel like a smart, hassle-free decision.

Vikram Singh

Vikram Singh

Financial Consultant

Starting my SIP journey with KSquare was the best decision. Their platform is intuitive, and I feel secure knowing my money is growing steadily.

Tanya Arora

Tanya Arora

Teacher

Being self-employed, I wanted a structured way to invest. KSquare’s SIPs fit the bill. It’s affordable, effective, and easy to track progress over time.

Kritika Jain

Kritika Jain

Event Planner

I never thought NPS could be this simple. KSquare gave me full control and transparency over my retirement planning.

Ishita Raina

Ishita Raina

Legal Assistant

It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!

Neeti Bajoria

Neeti Bajoria

Language Trainer

KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.

Yash Khanna

Yash Khanna

Engineer

FAQ's

Frequenlty Asked Question

Does KSquare offer mutual funds for tax savings?

Yes, KSquare offers ELSS mutual funds, which are eligible for tax deductions under Section 80C up to ₹1.5 lakh.

What if I need money before my SIP goal time?

Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.

How does KSquare help with mutual fund selection?

KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.

What if I fail to repay the loan on time?

In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.

Can I prepay the loan without penalties?

Most lenders allow prepayment without extra charges. KSquare ensures these terms are clearly shared before you proceed.

How do I track my NPS account with KSquare?

You can log in to your KSquare dashboard to see real-time NAVs, contributions, and returns from your NPS account.

Why should I choose KSquare over other platforms for NRI investing?

KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.

Are NFOs safe for first-time investors?

NFOs can be suitable for beginners, but they carry risks. KSquare helps assess fund strategies before you commit.

App Store